Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, shared a post on LinkedIn about a recent article he and his colleagues co–authored, adding:
“Just how do physicians and patients think about risk when considering lipid modification therapies.
7 country perspective from our Interaspire.”
Title: Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions – insights from the INTERASPIRE study
Authors: Chathurangani Menaka Balasooriya, Catriona Jennings, Eanna Kenny, Dirk De Bacquer, Kausik Kumar Ray, John-Paul Corry, Agnieszka Adamska, Kornelia Kotseva, John W McEvoy, Chris Noone, Sandra Ganly, Juwairia Alali, Wael Al Mahmeed, Nooshin Bazargani, Junbo Ge, Rose Hui-Chin Jong, Diana Hui-Ping Foo, Yong Huo, Paula Luna Bonilla, Nancy Xinrong Ji, Piotr Jankowski, Yong Li, Amam Mbakwem, Lilian Mbau, Okechukwu Samuel Ogah, Elijah N Ogola, Adalberto Quintero-Baiz, Mahmoud Umar Sani, Miguel A Urina-Triana, Renata Wolfshaut-Wolak, Ahmad Syadi Mahmood Zuhdi, David Allan Wood, Jaimini Cegla
Read the Full Article on American Journal of Preventive Cardiology
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention